Duration and morbidity of chronic immune thrombocytopenic purpura in children: Five-year follow-up of a Nordic cohort

Acta Paediatrica, International Journal of Paediatrics

Volumn 101, Issue 7, 2012, Pages 761-766

  Rosthøj, Steen ^a   Rajantie, Jukka ^b   Treutiger, Iris ^c   Zeller, Bernward ^d   Tedgård, Ulf ^e   Henter, Jan Inge ^f  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^c SACHS CHILDREN S HOSPITAL   (Sweden)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic ITP; Platelets; Thrombocytopenia

Indexed keywords

ADOLESCENT; ARTICLE; BLEEDING; CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; COHORT ANALYSIS; CONVALESCENCE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HEMOLYTIC ANEMIA; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; INFECTION; INTRAOCULAR HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MUCOSAL BLEEDING; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SCHOOL CHILD; SEPSIS; SKIN BLEEDING; SPLENECTOMY; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 85027919805     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2012.02671.x     Document Type: Article

References (32)

1. Zeller B, Rajantie J, Hedlund-Treutiger I, et al., Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr 2005; 94: 178-84.
2. Hedman A, Henter J-I, Hedlund I, Elinder G,. Prevalence and treatment of chronic idiopathic thrombocytopenic purpura of childhood in Sweden. Acta Paediatr 1997; 86: 226-7.
3. Tamary H, Kaplinsky C, Levy I, et al., Chronic childhood idiopathic thrombocytopenic purpura: long-term follow-up. Acta Paediatr 1994; 83: 931-4.
4. Aronis S, Platokouki H, Mitsaka A, Haidas S, Constantopoulos A,. Seventeen years of experience with chronic idiopathic thrombocytopenic purpura in childhood. Is therapy always better? Pediatr Hematol Oncol 1995; 12: 407-10.
5. Reid MM,. Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome. Arch Dis Child 1995; 72: 125-8.
6. Wong MS, Chan GC, Ha SY, Lau YL,. Clinical characteristics of chronic idiopathic thrombocytopenia in Chinese children. J Pediatr Hematol Oncol 2002; 24: 648-52.
7. Watts RG,. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the Childrens Hospital of Alabama. Clin Pediatr 2004; 43: 691-702.
8. Jayabose S, Levendoglu-Tugai O, Ozkaynkak MF, Visintainer P, Sandoval C,. Long-term outcome of chronic idiopathic thrombocytopenic purpura in children. J Pediatr Hematol Oncol 2004; 26: 724-6.
9. Donato H, Picon A, Rapetti MC, et al., Splenectomy and spontaneous remission in children with chronic idiopathic thrombocytopenic purpura. Pediatr Blood Cancer 2006; 47: 737-9.
10. Ruggiero A, Annunziata ML, Lazzareschi I, Ridola V, Attina G,. Chronic idiopathic thrombocytopenic purpura in children: case reports of spontaneous recovery without splenectomy. Pediatr Hematol Oncol 2006; 23: 471-5.
11. Kubota M, Adachi S, Usami I, Okada M, Kitoh T, Shiota M, et al., Characterization of chronic idiopathic thrombocytopenic purpura in Japanese children: a retrospective multi-center study. Int J Hematol 2010; 91: 252-7.
12. Bansal D, Bhamare TA, Trehan A, Ahluwalia J, Varma N, Marwaha RK,. Outcome of chronic idiopathic thrombocytopenic purpura in children. Pediatr Blood Cancer 2010; 54: 403-7.
13. Tait RC, Evans DIK,. Late spontaneous recovery of chronic thrombocytopenia. Arch Dis Child 1993; 68: 680-1.
14. Buchanan GR, Journeycake JM, Adix L,. Severe chronic thrombocytopenic purpura during childhood: definition, management, and prognosis. Semin Thromb Hemost 2003; 29: 595-603.
15. Butros LJ, Bussel JB,. Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J Pediatr Hematol Oncol 2003; 25: 660-4.
16. Klaassen RJ, Blanchette VS, Barnard D, et al., Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP tools. J Pediatr 2007; 150: 510-5.
17. Kühne T, Blanchette V, Buchanan GR, et al., Splenectomy in children with idiopathic thrombocytopenic purpura: a prospective study of 134 children from the Intercontinental Childhood ITP Study Group. Pediatr Blood Cancer 2007; 49: 829-34.
18. Kühne T, Freedman J, Semple JW, Doyle J, Butchard S, Blanchette VS,. Platelet and immune response to oral cyclic dexamethasone therapy in childhood immune thrombocytopenic purpura. J Pediatr 1997; 130: 17-24.
19. Mueller BU, Bennett CM, Feldman HA, et al., One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura treated with Rituximab. Pediatr Blood Cancer 2009; 52: 259-62.
20. Bussel JB, Kuter DJ, George JN, et al., AMG 531, a thrombopoiesis- stimulating protein, for chronic ITP. N Engl J Med 2006; 355: 1672-81.
21. Bussel JB, Cheng G, Saleh MN, et al., Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007; 357: 2237-47.
22. Bussel JB, Buchanan GR, Nugent DJ, Gnarra DJ, Bomgaars LR, Blanchette VS, et al., A randomized, double-blind study of romiplostin to determine its safety and efficacy in children with immune thrombocytopenia (ITP). Blood 2011; 118: 28-36.
23. Rosthøj S, Hedlund-Treutiger I, Ajantie J, et al,. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort. J Pediatr 2003; 143: 302-7.
24. Buchanan GR, Adix L,. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 2002; 141: 683-8.
25. Rodeghiero F, Stasi R, Gernsheimer T, et al., Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113: 2386-93.
26. Imbach P, Kühne T, Müller D, et al., Childhood ITP: 12 months follow-up from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer 2006; 46: 351-6.
27. Lilleyman JS, on behalf of the Pediatric Haematology Forum of the British Society for Haematology. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child 1994; 71: 251-3.
28. Psaila B, Petrovic A, Page LK, Menell J, Schonholz M, Bussel JB,. Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood 2009; 114: 4777-83.
29. British Committee for standards in general haematology task force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574-96.
30. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al., International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168-86.
31. Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA,. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190-207.
32. Neunert CE, Bright BC, Buchanan G,. Severe chronic refractory immune thrombocytopenic purpura during childhood: a survey of physician management. Pediatr Blood Cancer 2008; 51: 513-6.